Compound for Alzheimer's combats bacterial resistance to last-resort antibiotics in mice

An experimental drug for neurodegenerative diseases can also reverse resistance to "last-resort" polymyxin antibiotics among bacteria that cause sepsis, a life-threatening complication from infections. Read more